Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -11304.83% is 50% below its 5-year average of -7542.10%, near the high end of its 5-year range (-57385.00%–1953.75%).
3.91% below its 12-month average of -10879.07%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -11729.41%.
NET PROFIT MARGIN
-11304.83%
NET PROFIT MARGIN AVG TTM
-10879.07%
NET PROFIT MARGIN AVG 3Y
-9862.08%
NET PROFIT MARGIN AVG 5Y
-7542.10%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-3.91%
CURRENT VS 3Y AVG
-14.63%
CURRENT VS 5Y AVG
-49.89%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 631 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Envoy Medical, Inc.
Market Cap
$51.33M
Net Profit Margin
-11304.83%
TTM Avg
-10879.07%
3Y Avg
-9862.08%
5Y Avg
-7542.10%
Market Cap
$50.92M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$50.42M
Net Profit Margin
-128.69%
TTM Avg
-13664.85%
3Y Avg
-30726.86%
5Y Avg
-811138.03%
Market Cap
$50.25M
Net Profit Margin
-91866.00%
TTM Avg
-196225.86%
3Y Avg
-104777.73%
5Y Avg
-90977.38%
Market Cap
$52.68M
Net Profit Margin
N/A
TTM Avg
-24.71%
3Y Avg
-12.36%
5Y Avg
-8.24%
Market Cap
$53.01M
Net Profit Margin
-5668.62%
TTM Avg
-3356.71%
3Y Avg
-1974.47%
5Y Avg
-1414.89%
Market Cap
$49.26M
Net Profit Margin
-20059.90%
TTM Avg
-12303.49%
3Y Avg
-9625.39%
5Y Avg
-8201.08%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Envoy Medical, Inc. (COCH) | $51.33M | -11304.83% | -10879.07% | -9862.08% | -7542.10% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $50.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| Apollomics, Inc. (APLM)vs › | $50.42M | -128.69% | -13664.85% | -30726.86% | -811138.03% |
| INmune Bio, Inc. (INMB)vs › | $50.25M | -91866.00% | -196225.86% | -104777.73% | -90977.38% |
| biote Corp. (BTMD)vs › | $52.49M | 3.19% | 7.83% | 4.22% | 10.88% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $52.68M | N/A | -24.71% | -12.36% | -8.24% |
| ImageneBio Inc (IMA)vs › | $53.01M | -5668.62% | -3356.71% | -1974.47% | -1414.89% |
| eXoZymes, Inc. (EXOZ)vs › | $53.09M | 0.00% | 0.00% | 0.00% | 0.00% |
| Clene Inc. (CLNN)vs › | $49.26M | -20059.90% | -12303.49% | -9625.39% | -8201.08% |
| Microbot Medical Inc. (MBOT)vs › | $48.99M | -4722.25% | 0.00% | 0.00% | 0.00% |
Operating Margin
-9240.7%
Net Profit Margin
-11304.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -11729.41% |
| 2026-03-31 | -11156.41% |
| 2025-12-31 | -8781.33% |
| 2025-09-30 | -15433.33% |
| 2025-06-30 | -7294.87% |
| 2025-03-31 | -10865.22% |
| 2024-12-31 | -10995.24% |
| 2024-09-30 | -10642.86% |
| 2024-06-30 | -5804.41% |
| 2024-03-31 | -10627.12% |
| 2023-12-31 | -5152.63% |
| 2023-09-30 | 1953.75% |
| 2023-06-30 | -21025.40% |
| 2023-03-31 | -16991.03% |
| 2022-12-31 | -57385.00% |
| 2022-09-30 | -2349.12% |
| 2022-06-30 | -2094.92% |
| 2022-03-31 | -1852.48% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
